[HTML][HTML] Coping strategies for pertussis resurgence
X Nian, H Liu, M Cai, K Duan, X Yang - Vaccines, 2023 - mdpi.com
Pertussis (whooping cough) is a respiratory disease caused primarily by Bordetella
pertussis, a Gram-negative bacteria. Pertussis is a relatively contagious infectious disease in …
pertussis, a Gram-negative bacteria. Pertussis is a relatively contagious infectious disease in …
[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …
FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Background Two Tdap vaccines are licensed for use in the United States. Boostrix
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …
[HTML][HTML] Recommendations for adult immunization by the Korean Society of Infectious Diseases, 2023: minor revisions to the 3rd edition
Abstract The Korean Society of Infectious Diseases has been regularly developing
guidelines for adult immunization since 2007. In 2023, the guidelines for the following seven …
guidelines for adult immunization since 2007. In 2023, the guidelines for the following seven …
[HTML][HTML] Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study
F Werner, N Zeschick, T Kühlein, P Steininger… - BMC medicine, 2023 - Springer
Background In the course of the SARS-CoV-2 pandemic, multiple vaccines were developed.
Little was known about reactogenicity and safety in comparison to established vaccines, eg …
Little was known about reactogenicity and safety in comparison to established vaccines, eg …
[HTML][HTML] Improving vaccination rates in older adults and at-risk groups: focus on pertussis
JH Choi, J Correia de Sousa, M Fletcher… - Aging Clinical and …, 2022 - Springer
Despite the implementation of effective paediatric vaccination programmes, pertussis
remains a global health problem. Disease epidemiology has changed over time, shifting …
remains a global health problem. Disease epidemiology has changed over time, shifting …
[HTML][HTML] Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients–Lessons learned from the COVID-19 pandemic
Despite the development of new biological and synthetic targeted therapies, methotrexate
remains one of the most commonly used immunomodulatory drugs in rheumatology …
remains one of the most commonly used immunomodulatory drugs in rheumatology …
Seroprevalence of Bordetella pertussis Infection in Patients With Chronic Obstructive Pulmonary Disease in England: Analysis of the AERIS Cohort
TMA Wilkinson, P Van den Steen… - COPD: Journal of …, 2021 - Taylor & Francis
Pertussis is underdiagnosed and underreported in adults and patients with underlying
conditions. Patients with chronic obstructive pulmonary disease (COPD) may be at …
conditions. Patients with chronic obstructive pulmonary disease (COPD) may be at …
[HTML][HTML] Establishment of safety monitoring system for vaccines not included in the national immunization program in Korea
Background In Korea, there are no surveillance programs for vaccines that are not included
in the national immunization program (NIP), and vaccine safety monitoring in the adult …
in the national immunization program (NIP), and vaccine safety monitoring in the adult …
[HTML][HTML] Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria …
D Brandon, M Kimmel, SO Kuriyakose, L Kostanyan… - Vaccine, 2018 - Elsevier
Background Over the last decades, pertussis showed periodic increases in its incidence
among adults, despite being a vaccine-preventable disease. Methods This phase III …
among adults, despite being a vaccine-preventable disease. Methods This phase III …
Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States
Abstract Background In the United States, persons≥ 11 years are recommended to receive
one dose of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) …
one dose of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) …